|Last Updated:||February 1, 2004|
|Other Name:||Centro de Investigaciones Biologicos, CIB|
The center became involved in recombinant DNA research during the 1980s, following its success at developing methods for producing interferon. From 1982 through 1986, researchers "gained experience in enlarging the scale of fermentation and purification of biomolecules." In the mid-1980s, scientists achieved success in working with gene manipulation, molecular virology, immunochemistry, and tissue cultures. By 1986, CIB had been divided into four different laboratories: genetic engineering, immunology, chemistry, and fermentation. According to a UN University publication, current (as of 1994) CIB research includes synthesis of oligonucleotides, cloning and expression of a number of other genes, and production of monoclonal antibodies. Other researchers at CIB are focused on immunology, immunochemistry, protein purification, and fermentation.
According to Charles Cooper of the UN University, CIB was a major beneficiary of imported Soviet scientific techniques, and many of its researchers were trained in the USSR. Most had a significant education in organic chemistry and were able to adapt this knowledge to the performance of recombinant DNA research.
Following the creation of the Center for Genetic Engineering and Biotechnology (CIGB), CIB was merged with CIGB, becoming a branch research office in Havana.
 Charles Cooper (ed.), Technology and Innovation in the International Economy (Maastricht, Holland: Edward Elgar, United Nations University Press, 1994), p. 2.4.4.
 Manuel Limonta, "Biotechnology and the Third World: Development Strategies in Cuba," Biomedical Science and the Third World, ed., Barry Bloom and Anthony Cerami, (New York: New York Academy of Sciences, 1989), pp. 325-333.
 M. Elderhorst, "Will Cuba's biotechnology capacity survive the socio-economic crisis?" Biotechnology and Development Monitor, No. 20, pp. 11-13, 22.